Dacogen 50 Injection 1's
About Dacogen 50 Injection 1's
Dacogen 50 Injection 1's belongs to the group of medicines called hypomethylation agents used to treat myelodysplastic syndrome. A myelodysplastic syndrome is a group of malignancies known as myelodysplastic syndromes that occur when immature blood cells in the bone marrow do not mature or turn into healthy blood cells.
Dacogen 50 Injection 1's contains ‘Decitabine’, which works by helping the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow.
Decitabine should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer chemotherapeutic agents. Decitabine should usually be given for at least four cycles but may be continued if your doctor decides you will benefit from additional treatment. The most common adverse reactions of Dacogen 50 Injection 1's are injection site reactions, excessive tiredness, headache, dizziness, confusion, fast heartbeat, difficulty falling asleep or staying asleep, weakness, shortness of breath, nausea, constipation, diarrhoea, vomiting, heartburn, chest discomfort and swelling of the hands, feet, ankles, lower legs, or stomach. Talk with your doctor if you experience any of these side effects persistently.
Decitabine may harm your fetus. Avoid taking Dacogen 50 Injection 1's if you are pregnant or breastfeeding. You or your partner should not become pregnant while you are using decitabine. It would be best if you used birth control to prevent pregnancy in yourself or your partner during your treatment with decitabine and for two months afterwards. Call your doctor if you or your partner becomes pregnant while using decitabine. If you are breastfeeding. Do not breastfeed while you take this drug and for two weeks after your last dose. Dacogen 50 Injection 1's may cause dizziness, sleepiness, tiredness, and blurred vision, so drive only if alert. Dacogen 50 Injection 1's is not recommended for children below 18 years as safety and effectiveness have not been established. Inform your doctor about your health condition and medications before taking Dacogen 50 Injection 1's to rule out interactions.
Uses of Dacogen 50 Injection 1's
Medicinal Benefits
Dacogen 50 Injection 1's belongs to the group of medicines called hypomethylation agents used to treat myelodysplastic syndrome. Dacogen 50 Injection 1's contains ‘Decitabine’, which works by helping the bone marrow produce normal blood cells and kills abnormal cells in the bone marrow. On the other hand, it can treat blood cancer, known as acute myeloid leukemia (AML).
Directions for Use
Storage
Side Effects of Dacogen 50 Injection 1's
Drug Warnings
Before taking the Dacogen 50 Injection 1's, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Before and during your therapy, your doctor will prescribe laboratory testing on a regular basis. You may have a higher risk of infection. Hands must be washed frequently. Avoid contact with those who have illnesses, colds, or the flu. You may bleed more easily. Take precautions to avoid injury. Do not skip any scheduled dose or take other medications unless prescribed by the doctor.
Drug Interactions
Drug-Drug Interactions: Dacogen 50 Injection 1's may interact with medicines used to treat rheumatoid and psoriatic arthritis (e.g. adalimumab, baricitinib, leflunomide), vaccinations (e.g. BCG vaccine, dengue vaccine, yellow fever vaccine), antipsychotic medication (e.g. clozapine).
Drug-Food Interactions: Avoid the consumption of alcoholic beverages.
Drug-Disease Interactions: Dacogen 50 Injection 1's may interact with various disease conditions, including liver, kidney and haematological toxicities (Low platelet level, low count of a type of white blood cell).
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Myelodysplastic syndromes: Myelodysplastic syndromes are malignancies in which immature blood cells in the bone marrow do not mature and do not become healthy blood cells. Abnormalities in blood cells and bone marrow distinguish the many forms of myelodysplastic syndromes.